Key Takeaways
- • Carlyle and PAI Partners have agreed to sell specialty pharmaceutical company Theramex, according to PEI Private Equity's newsletter coverage.
- • O2 Investment Partners has sold Xobee Networks to Brite, per the same report.
- • Kristin Kelly, a partner at Houston-based energy-focused private equity firm EIV Capital, discusses the resilience of the oil and gas sector in PEI's Dealmakers to Watch profile.
- • Submissions for the PEI Private Equity Awards 2026 are now open.
Summary
Carlyle and PAI Partners have agreed to sell specialty pharmaceutical company Theramex, according to PEI Private Equity. The source describes the transaction as an exit for both sponsors but the available coverage does not disclose a buyer, valuation or deal value.
Separately, O2 Investment Partners has sold Xobee Networks to Brite. The available report does not provide financial terms for that transaction.
PEI's latest profile in its Dealmakers to Watch series features Kristin Kelly, a partner at Houston-based EIV Capital, an energy-focused private equity firm. The profile addresses the resilience of the oil and gas sector, though the excerpt available for this summary does not include her specific commentary or figures.
PEI also announced that submissions for the PEI Private Equity Awards 2026 are open. The awards call is a promotional item rather than a market development.
Separately, O2 Investment Partners has sold Xobee Networks to Brite. The available report does not provide financial terms for that transaction.
PEI's latest profile in its Dealmakers to Watch series features Kristin Kelly, a partner at Houston-based EIV Capital, an energy-focused private equity firm. The profile addresses the resilience of the oil and gas sector, though the excerpt available for this summary does not include her specific commentary or figures.
PEI also announced that submissions for the PEI Private Equity Awards 2026 are open. The awards call is a promotional item rather than a market development.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.